Due to a high load of modelling projects, the rate of submission via the website has been reduced.
For a much higher submission rate, please use the Modelling API.

A0A3S4RPI7 (A0A3S4RPI7_PSEFL) Pseudomonas fluorescens

UDP-3-O-acyl-N-acetylglucosamine deacetylase UniProtKBInterProInteractive Modelling

303 aa; Sequence (Fasta) ; 5 identical sequences: Pseudomonas aeruginosa: B7UZI4, A0A072ZC86; Pseudomonas sp. FDAARGOS_761: A0A6N0KED4; Pseudomonas aeruginosa: P47205; Pseudomonas aeruginosa BL04: A0A1C7BHD4

Available Structures

63 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Crystal Structure of LpxC from Pseudomonas aeruginosa complexed with the potent BB-78485 inhibitorhomo-3-mer1-299
ZN;GVR;SO4;
Assess
Crystal structure of LpxC from Pseudomonas aeruginosa in complex with PT805monomer1-299
EUY;ZN;CL; 17×EDO;
Assess
UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase in complex with inhibitormonomer1-299
ZN;RFN;GAI;EDO;
Assess
Crystal structure of LpxC from Pseudomonas aeruginosa in complex with PT801monomer1-299
HAY;J1M;ZN;CL;EDO;
Assess
Crystal structure of P.aeruginosa LpxC in complex with inhibitormonomer1-299
FYR;DMS;ZN;
Assess
Crystal structure of LpxC from Pseudomonas aeruginosa in complex with ligand PT802monomer1-299
HUM;JCG;ZN;CA;CL;
Assess
Crystal structure of LpxC from Pseudomonas aeruginosa in complex with PF-5081090monomer1-299
8GJ;ZN;CL;EDO;
Assess
Crystal Structure of the LpxC in complex with N-[(2S,3R)-3-HYDROXY-1-(HYDROXYAMINO)-1-OXOBUTAN-2-YL…monomer1-299
ZN;L63;GOL;ACT;
Assess
Structure of P. aeruginosa LpxC with compound 8: (2RS)-4-(5-(2-Fluoro-4-methoxyphenyl)-2-oxooxazol-…monomer1-299
ZN;H2N;GOL;
Assess
LpxC Inhibitors With Fluoroproline As A Novel Zinc-Binding Group Can Serve As A Novel Class of Anti…monomer1-299
ZN;7S6;
Assess
CHAIN A. UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase PA-LPXC Complexed with (R)-3-…monomer1-299
JBA;ZN;
Assess
Crystal structure of UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase (LpxC) from Pseud…monomer1-299
C90;ZN;CL;CA;EDO;
Assess
Crystal Structure of the LpxC in complex with N-[(2S,3R)-3-HYDROXY-1-(HYDROXYAMINO)-1-OXOBUTAN-2-YL…monomer1-299
ZN;L59;GOL;ACT;PEG;
Assess
Crystal structure of P.aeruginosa LpxC in complex with inhibitormonomer1-299
FYL;PO4;EDO;ZN;
Assess
LpxC Inhibitors With Fluoroproline As A Novel Zinc-Binding Group Can Serve As A Novel Class of Anti…monomer1-299
ZN;7PX;
Assess
Crystal Structure of P. aeruginosa LpxC with N-Hydroxyformamide inhibitor 19monomer1-299
GOL;W4M;SO4;ZN;
Assess
Structure of P. aeruginosa LpxC with compound 10: (2RS)-4-(5-(2-Fluoro-4-methoxyphenyl)-1-oxoisoind…monomer1-299
ZN;UNY;UNZ;
Assess
Crystal structure of P.aeruginosa LpxC in complex with inhibitormonomer1-299
ZN;H4O;
Assess
Crystal structure of Pseudomonas aeruginosa LpxC complexed with inhibitormonomer1-299
ZN;8Q8;CL;
Assess
Crystal structure of P.aeruginosa LpxC in complex with inhibitormonomer1-299
MPB;ZN;
Assess
LpxC Inhibitors With Fluoroproline As A Novel Zinc-Binding Group Can Serve As A Novel Class of Anti…monomer1-299
ZN;9DO;
Assess
Structure of P. aeruginosa LpxC with compound 17a: (2R)-N-Hydroxy-2-methyl-2-(methylsulfonyl)-4(6((…monomer1-299
ZN;H2Z;
Assess
Crystal Structure of the LpxC in complex with 4'-BROMO-N-[(2S,3R)-3-HYDROXY-1-(HYDROXYAMINO)-1-OXOB…monomer1-299
ZN;L58;ACT;GOL;
Assess
Potent Inhibitors of LpxC for the Treatment of Gram-Negative Infectionsmonomer1-299
ZN;03I;
Assess
Crystal structure of P.aeruginosa LpxC in complex with inhibitormonomer1-299
FXU;ZN;MG;CL;
Assess
Pseudomonas aeruginosa LpxC in complex with NVS-LPXC-01monomer1-299
ZN;7TD;EPE;
Assess
Crystal Structure of P. aeruginosa LpxC with N-Hydroxyformamide inhibitormonomer1-299
W4P;SO4;GOL;DMS;ZN;
Assess
Pseudomonas LpxC in complex with LPC-233monomer1-299
ZN;UFX;
Assess
LpxC Inhibitors With Fluoroproline As A Novel Zinc-Binding Group Can Serve As A Novel Class of Anti…monomer1-299
ZN;7S2;
Assess
LpxC from P.aeruginosa with the inhibitor 6-(benzimidazol-1-yl)-5-[4-[2-[6-[(4-methylpiperazin-1-yl…monomer1-299
ZN;2SZ;
Assess
Crystal structure of P.aeruginosa LpxC in complex with inhibitormonomer1-299
ZN;H4R;
Assess
LpxC Inhibitors With Fluoroproline As A Novel Zinc-Binding Group Can Serve As A Novel Class of Anti…monomer1-299
ZN;6G8;
Assess
Crystal structure of P.aeruginosa LpxC in complex with inhibitormonomer1-299
FY9;ZN;
Assess
LpxC Inhibitors With Fluoroproline As A Novel Zinc-Binding Group Can Serve As A Novel Class of Anti…monomer1-299
ZN;99I;
Assess
Crystal structure of P.aeruginosa LpxC in complex with inhibitormonomer1-299
ZN;H4L;
Assess
Crystal Structure of the LpxC in complex with N-[(1S,2R)-2-HYDROXY-1-(HYDROXYCARBAMOYL)PROPYL]-4-(4…monomer1-299
ZN;3P3;
Assess
Structure of P. aeruginosa LpxC with compound 12: (2R)-4-(6-(2-Fluoro-4-methoxyphenyl)-3-oxo-1H-pyr…monomer1-299
ZN;H2H;EDO;
Assess
Structure of P. aeruginosa LpxC with compound 18d: (2R)-N-Hydroxy-4-(6-((1-(hydroxymethyl)cycloprop…monomer1-299
ZN;H2Q;
Assess
LpxC Inhibitors With Fluoroproline As A Novel Zinc-Binding Group Can Serve As A Novel Class of Anti…monomer1-299
ZN;7T5;EDO;
Assess
Crystal Structure of the LpxC in complex with N-[(2S)-3-AMINO-1-(HYDROXYAMINO)-1-OXOPROPAN-2-YL]-4-…monomer1-299
ZN;L52;GOL;
Assess
LpxC Inhibitors With Fluoroproline As A Novel Zinc-Binding Group Can Serve As A Novel Class of Anti…monomer1-299
ZN;8IY;
Assess
LpxC Inhibitors With Fluoroproline As A Novel Zinc-Binding Group Can Serve As A Novel Class of Anti…monomer1-299
ZN;98O;
Assess
LpxC Inhibitors With Fluoroproline As A Novel Zinc-Binding Group Can Serve As A Novel Class of Anti…monomer1-299
ZN;7TF;
Assess
Crystal structure of P.aeruginosa LpxC in complex with inhibitormonomer1-299
FY6;ZN;CL;
Assess
Crystal structure of P.aeruginosa LpxC in complex with inhibitormonomer1-299
FYF;ZN;
Assess
Crystal structure of the Pseudomonas aeruginosa LPXC/LPC-014 complexmonomer1-298
ZN;1WL; 11×NO3;
Assess
Co-Crystal structure of P. aeruginosa LpxC-50067 complexmonomer2-299
MG;JWM;
Assess
Co-Crystal structure of P. aeruginosa LpxC-50432 complexmonomer2-299
MG;JWV;GOL;
Assess
Co-Crystal structure of P. aeruginosa LpxC-50228 complexmonomer2-299
JWP;MG;
Assess
Co-Crystal structure of P. aeruginosa LpxC-achn975 complexmonomer2-299
ZN;A5F;
Assess
Crystal Structure of the PSEUDOMONAS AERUGINOSA LpxC/LPC-009 complexmonomer1-297
ZN;3P3;NA; 25×NO3;
Assess
Pseudomonas aeruginosa LpxC in complex with a hydroxamate inhibitormonomer1-297
ZN;1JS;
Assess
Crystal structure of the Pseudomonas aeruginosa LPXC/LPC-050 complexmonomer1-296
ZN;1WM; 16×NO3;
Assess
Crystal structure of the Pseudomonas aeruginosa LpxC/LPC-058 complexmonomer1-296
ZN;5EN; 17×NO3;
Assess
Crystal structure of the Pseudomonas aeruginosa LPXC/LPC-051 complexmonomer1-296
ZN;1WN; 16×NO3;
Assess
Crystal structure of the Pseudomonas aeruginosa LpxC/LPC-040 complexmonomer1-296
ZN;5EM; 29×NO3;
Assess
LpxC Inhibitors With Fluoroproline As A Novel Zinc-Binding Group Can Serve As A Novel Class of Anti…monomer1-294
ZN;9A1;
Assess
LpxC Inhibitors With Fluoroproline As A Novel Zinc-Binding Group Can Serve As A Novel Class of Anti…monomer1-293
ZN;9B9;
Assess
Crystal structure of P.aeruginosa LpxC in complex with inhibitormonomer1-288
FZ0;ZN;
Assess
Crystal structure of P.aeruginosa LpxC in complex with inhibitormonomer1-288
FXX;MPO;ZN;
Assess
Pseudomonas aeruginosa LpxC in complex with CHIR-090monomer2-288
ZN;C90;
Assess
Crystal structure of P.aeruginosa LpxC in complex with inhibitormonomer1-287
FZ6;ZN;
Assess
Crystal structure of P.aeruginosa LpxC in complex with inhibitormonomer1-286
FZ3;DMS;ZN;
Assess

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
5u3b.1.Amonomer0.891-299
ZN;7TD;100.00
Assess